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Abstract 
It is believed that children are more sensitive to ionising radiation than adults. This 
work reviewed the reported radiation dose estimates for paediatric cardiac 
catheterisation. A systematic literature review was performed by searching healthcare 
databases for studies reporting radiation dose using predetermined key words relating 
to children having cardiac catheterisation. The quality of publications was assessed 
using relevant Critical Appraisal Skills Programme questions and their reported 
radiation exposures were evaluated. 
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Introduction 
Children undergoing paediatric cardiac catheterisation (PCC) receive essential 
diagnosis and treatment of congenital heart disease (CHD).  The greatest radiation 
doses may occur during complex procedures, which are likely to involve longer 
fluoroscopy times (FT) and digital acquisitions.  Radiation exposures in PCC are 
justified because the benefit outweighs the risk in accordance with national and 
European guidelines[1-2].  A number of factors affect radiation dose including the type 
and complexity of CHD, imaging protocols, X-ray equipment, and operator 
experience.  Furthermore, there exists a large variation in patient size, as well as type 
of radiation dose units used for dosimetry, potentially causing confusion for 
clinicians.  The development of new technology continues to potentially affect the 
radiation dose in PCC.  During the last decade there have been major technological 
advances in surgical equipment used in PCC such as the amplatzer closure device for 
patent ductus arteriosus (PDA) interventions[3].  Likewise imaging equipment in 
developed countries has transitioned from the use of image intensifier (II) to flat panel 
detector (FPD) technology.  A recent survey of clinical centres in the United 
Kingdom (UK) (n=13) and Ireland (n=1) demonstrated that more than half of 
surveyed centres were using FPDs during PCC[4].  A review of published radiation 
doses in PCC is necessary to provide clinicians and researchers with an accurate 
depiction of current clinical radiation exposures.  The aim of our work was to perform 
a systematic literature review to determine the current radiation doses reported from 
PCC. 
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Methodology  
The systematic literature search was performed using the following healthcare 
databases:  Medline (1949 - present), Pubmed (1947 - present), Science Direct (1823 - 
present), Cumulative Index to Nursing and Allied Health (CINAHL) (1937 - present) 
and the Cochrane Library Database (1974 - present).  The Transparent Reporting of 
Systematic Reviews and Meta-Analysis group flow chart demonstrates the search 
strategy used[5] (Figure 1).  The “Medical Subject Heading” (MeSH) was used to help 
identify related keywords (Table 1).  The reference list of each relevant article was 
searched for additional publications and a zetoc alert was set up to identify current 
and future publications (www.zetoc.mimas.ac.uk).  Identified articles were included if 
they were in English, measured radiation dose in PCC and were fully peer reviewed.  
Articles were excluded if they were review articles or if they only observed dose in 
patients >18 years of age.  Each study was assessed by one reviewer using a scoring 
scale based on selecting 7 relevant cohort study Critical Appraisal Skills Programme 
(CASP)[6] as follows: (i) Did the study address a clearly focused issue? (ii) Was the 
cohort recruited in an acceptable way? (iii) Was the radiation dose accurately 
measured to minimise bias? (iv) Have the authors identified and taken into account 
confounding factors? (v) Do you believe the results? (vi) Can the results be applied to 
the local population? (vii) Do the results of the study fit with other available 
evidence?  Two additional reviewers assessed the resultant scores given by reviewer 
one. 
 
Results  
The literature review search results are summarised in Table 2.  The additional 
reviewers had no disagreements with the scoring of article quality.  Thirty-one 
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relevant articles were reviewed and included studies relating to radiation dose, dose 
optimisation, risk estimates, biological effects and image quality.  Approximately 
50% of studies were published from 2010 - 2015 yet accounted for 95% of the data 
observed in the literature.  The smallest studies consisted of 18 children [7-8] whilst the 
largest studies were performed in the United States of America (USA) and UK and 
consisted of 8,267 and 7,726 children respectively[9-10].  The most commonly 
observed measurements were dose area product (DAP) (n=26) and fluoroscopy time 
(n=23).  A larger number of studies provided data using an II (n=18) compared to a 
FPD (n=12).  The majority of studies presenting data from FPD (n=12) were 
published in the last 5 years (n=9).  The CASP quality scores were consistently high.  
All articles scored between 5 - 7 with a mean score of 6.  Radiation dose estimates by 
Verghese et al[11] (n=3,365) and Harbron et al[10] (n=7,726) demonstrated a clear 
decline in radiation doses in PCC from 2004 - 2008.  All but two small studies[12-13]     
stated that they had calibrated or performed quality assurance on their either their 
DAP meters or radiographic film. 
 
Articles presenting DAP as mean or median are demonstrated in Tables 3 - 4.  The 
majority of studies (90%) observed greater DAP from interventional procedures 
compared to diagnostic.  Mean diagnostic DAP ranged from 294 cGycm²[14] - 2,080 
cGycm²[8].  Mean DAP for interventional procedures ranged from 312.9 cGycm²[14] - 
10,900 cGycm²[8].  Median interventional DAP was as high as 30,067 cGycm².  This 
occurred with patients >16 years undergoing proximal right or left angioplasty and/or 
stent insertions[11].  In one imaging centre median DAP of 71,240 cGycm² was 
observed for diagnostic procedures all children observed[10].  In the same imaging 
centre however, this figure was found to be 2,740 cGycm² by 2010.  Interventional FT 
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was substantially greater compared to diagnostic FT in 15 of the 23 studies.  The 
highest reported diagnostic and interventional FTs were 41 minutes[14] and 77 
minutes[11,15] respectively.  However a median FT of 90 minutes was also reported for 
a pulmonary vein dilation procedure[11].  Children undergoing PDA and ASD closures 
resulted in the lowest radiation doses [11-12,16-19] whilst angioplasty, in particular 
pulmonary and right ventricular outflow tract angioplasty, resulted in the greatest 
radiation doses[11-12,17].   
 
Effective dose (E) estimates (Table 5) were greater for interventional procedures in 
studies that recorded data for both diagnostic and interventional procedures[20-22,17].  
The largest E estimate was 77 mS however no information was given on the 
procedure type[23].  
 
All but one study that recorded entrance surface dose (ESD) was published prior to 
2010 and consisted of relatively small cohorts (n=18 - 137).  The majority of studies 
observed greater ESD for interventional procedures compared to diagnostic.  Few 
studies provided specific minimum or maximum range of ESD however the largest 
observed ESD was 1,674 mGy[7].  Only five studies recorded and published air kerma 
(AK).  All of these articles were published since 2008.  Several authors observed 
greater AK for interventional procedures[11,18,24].  Although a greater range of AK for 
diagnostic procedures was reported by Harbron et al[10], in many of their observed 
procedures, the AK was not recorded.   
 
There was a paucity of peak skin dose (PSD) recordings with only four studies 
providing this data (Table 6).  Radiographic film was placed on the patients skin for 
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three studies[19-20,23], whilst Martinez et al[25] used correction factors in combination 
with exposure parameters to determine PSD.  The greatest PSD observations were 
made by Song et al[19] who published PSDs of up to 410 mGy for an ASD closure and 
1,020 mGy for a radiofrequency ablation procedure. 
 
Radiation dose observations were more commonly categorised according to age (n=8) 
compared to weight (n=4).  It was observed throughout the studies that radiation dose 
increased with age and weight, and regardless of patient size, radiation dose was 
greater for interventional procedures.  Observation of these studies found a better 
correlation between weight and radiation dose compared to age and radiation dose.  
Numerous authors observed no increase in radiation dose with increasing age[21,23,25-
27], however these studies represented smaller cohorts of between 40 - 249 children. 
 
Radiation dose was most commonly reported for the thyroid and gonads compared to 
the other internal organs (Table 7).  The lowest thyroid dose was 0.5 mGy for a 
diagnostic procedure[15], whilst the highest dose was 73.1 mGy from an unspecified 
procedure[7]. Greater mean thyroid dose was observed for interventional 
procedures[13,15,28-29].  Gonadal dose was much lower compared to the thyroid and 
ranged from 0.1 - 2.1 mGy with the highest dose observed by Papadopoulou et al[15] 
for an ASD procedure (2.1 mGy).  Only two studies performed radiation dose 
estimates to other internal organs, from which the heart, lungs, thymus and breast 
were estimated to receive the greatest radiation dose[16-17]. 
 
The types of digital acquisition data published varied considerably making it difficult 
to compare.  Mesbahi and Aslanabadi[30] recorded mean digital acquisition DAP (70 
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cGycm²) and AK (7.2 mGy) whilst Li et al[7] recorded the range of tube potentials (54 
- 125 kVp), tube currents (28 - 1080 mA) and digital acquisition times (42 - 133 secs).  
Tsapaki et al [27] recorded greater median digital acquisition DAP for interventional 
procedures (1,000 cGycm²) compared to diagnostic (120 cGycm²).  Meanwhile the 
mean number of digital acquisition acquisitions was greater for interventional 
procedures in three studies[20,24,31] reported a greater percentage of radiation dose from 
digital acquisitions compared to fluoroscopy during interventional procedures (77% 
versus 67%).  Chida et al[31] found that mean digital acquisition acquisitions were 
greatest for balloon dilatations (n=16.3).  Barnaoui et al [17] reported that the greatest 
mean number of digital frames occurred for “angioplasty” procedures (1,088). 
 
Discussion 
A broad systematic review identified 31 articles that made radiation dose estimates 
for PCC.  These articles were individually assessed using a CASP scoring assessment.  
In order to interpret radiation dose estimates it is important to understand the 
numerous radiation dose measurements reported.  AK is a measurement of the kinetic 
energy released in air and is measured in Gy[32].  In PCC, AK is measured at the 
interventional reference point, which approximates the location of the skin at 15 cm 
from the heart.  DAP, also known as the kerma air product is a quantity of radiation 
that reflects not only the dose but also the area of tissue irradiated.  The ESD is the 
skin dose at the point of intersection of the X-ray beam.  Unlike AK, the ESD 
includes all scatter radiation, thought to contribute to approximately 27 - 45%  of the 
skin dose[33].  The E is used to describe the detrimental effects of radiation exposure 
upon organs and is not a measurement of the amount of radiation but is an assessment 
of the link between the radiation dose received and the potential detrimental effect [34].  
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Finally, the PSD is the highest dose at any portion of a patients skin when several 
regions of the skin have been exposed to the X-ray beam[32]. 
 
Owing to the relative ease of obtaining DAP and FT from X-ray systems, these were 
the most widely published measurements.  Whilst DAP is a crucial measurement of 
the radiation dose the FT is a poor indicator of radiation dose.  Nonetheless FT 
continues to be recorded since times of >60 minutes are associated with an increased 
potential of deterministic skin injury[35].  In general, individual patients undergoing 
PCC have received significant ionising radiation doses, including DAPs greater than 
of 71,240 cGycm²[10], E up to 77.2 mSv[23], ESD up to 1674 mGy[7] and AK up to 
4,842 mGy[11].  In comparison an E from a single chest radiograph is approximately 
0.02 mSv[36].  The FT for patients undergoing PCC can be >90 mins[8].  In general, 
radiation dose varied considerably due to patient size and procedure type. 
 
The decline in observed radiation dose estimates in PCC from 2004 – 2008 by 
Verghese et al[11] and Harbron et al[10] appear attributed to the installation of newer X-
ray systems.  This is namely the widespread introduction of caesium iodide FPDs in 
clinical practice, which convert X-ray photon energy into electrical signal more 
efficiently than older II technology[37].  Other contributing aspects may include 
increasing awareness by clinicians for radiation dose optimisation for children and an 
increase in operator skill and experience.   The majority of studies demonstrated that 
radiation dose is generally greater for interventional procedures compared to 
diagnostic.  This is likely because interventional procedures are often more complex.  
Despite these findings there were numerous reports of diagnostic procedures resulting 
in a similar or greater radiation dose than interventional procedures [10-11,23,26,38].  
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Patient weight was an important factor on influencing radiation dose recordings given 
that the X-ray beam transverses a thicker volume of tissue and because the FOV is 
also increased.  The most recent publications made the important distinction between 
radiation dose and corresponding weight category[9-10,18,39].  These studies have 
provided benchmark data for future dosimetry in PCC according to patient weight.  It 
should be noted that no study presented data on chest circumference, which could be 
explored for potential classification for radiation dose.  This may provide a better 
correlation for radiation dose due to potential variation in patient shape.  For example 
a tall and slender child may be the same weight as a shorter and wider child yet they 
are likely to have a difference in their chest size.  Consequently the radiation beam 
would transverse a different volume of tissue and could therefore skew comparisons 
for radiation dose comparisons in weight groups.  
 
The number of studies that estimated E was relatively low compared to DAP 
recordings.  This is likely due to the complexity involved in estimating E whilst in 
comparison the DAP is readily available from X-ray systems.  The range of mean E 
observed in this review (3.42 - 26 mSv) was comparative to those observed in adults 
undergoing interventional cardiology procedures (7 - 17 mSv)[40-41]. 
 
The PSD, a more relevant measure for the risk of skin injury[35] was not commonly 
report in the reviewed articles.  A concern regarding skin dose is the potential to 
exceed the deterministic threshold of a 2,000 mGy to the skin.  Skin injuries are 
thought to be under-reported in clinical practice because the injury can be 
unrecognised or misdiagnosed because injury may manifest for several weeks or 
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years[41].  Older children appear to be more at risk because they receive greater 
amounts of radiation due to their greater size and there were some instances of 
potential for skin injury presented in the literature.  Recent work by Jones et al [42-43] 
to validate PSD estimation could help predict and treat patients who have received 
high doses of radiation during PCC.  Although the threshold PSD of 2,000 mGy was 
not exceeded in the observed studies, they consisted of low patient numbers ranging 
from 60 - 249[19-20,23,25].  Measurements of PSD therefore remain scarce.  Although no 
study in this review reported a skin injury, 15 radiation skin injuries from 1,311 
young adults undergoing cardiac catheterisation have been reported in the literature, 
with 3 of these patients >18 years of age[44].  The potential for skin injury should 
therefore be monitored. 
 
The radiosensitive thyroid and gonads were the two most commonly assessed internal 
organs. The thyroid received greater radiation dose than the gonads because it is in 
closer proximity to the primary X-ray beam and consequent scatter radiation.  Li et 
al[7] was the only study to measure radiation dose for both the right and left side of the 
thyroid.  They observed a greater mean dose for the right side (13.6 mGy) compared 
to the left (8.3 mGy) because the lateral X-ray beam emerges from the patients right 
side.  It is therefore more pertinent to assess radiation dose to the right side of the 
thyroid since this area receives the greatest dose.  It has only been in the last 2 years 
that data has been published regarding other internal organs such as the heart and 
lungs[10,16-17].  These studies have demonstrated that the lungs, breast, heart and 
thymus receive substantial amounts of radiation.  It may therefore be pertinent for 
future studies to further assess radiation exposure to these organs using film 
dosimetry on the anterior and posterior aspect of the chest.  This is particularly 
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relevant due to the revised recommendations by the International Commission on 
Radiological Protection (ICRP) 2007[45], whereby breast tissue was determined to be 
at a substantially increased risk of radiation induced cancer risk than previously 
thought.   When compared with organ dose observations in chest CT[46] the thyroid 
dose in PCC is similar whilst breast dose was reported to be 1.5 times greater by 
Barnaoui et al[17] and 9 times greater by Yakoumakis et al[16].   
 
In the period 2010 - 2015 the number of PCC dosimetry studies performed has 
doubled and the number of patients observed since 2010 now account for 95% of all 
observations published.  Large studies conducted in the USA[9,11,12,18] reported 
generally greater radiation exposure than the similar size study conducted by Harbron 
et al[10] in the UK.  Similarly lower doses were also observed in smaller studies 
conducted in the UK and Europe by Martinez et al[25], Dragusin et al[47] and 
McFadden et al[14]. These differences may be due to operator practice indicated by 
generally longer FT in the USA population.  Dose optimisation measures may also be 
better implemented in the UK and Europe such as collimation of the X-ray beam, 
length of digital acquisition, use of fluoroscopy instead of digital when possible, 
removal of the AS grid and the use of ultrasound guidance as an alternative to 
fluoroscopy.   
 
This review has demonstrated the transition from II technology used in older 
publications, to the use of FPDs in recent studies.  FPDs have been considered to offer 
greater patient dose saving[48].  Harbron et al[10] was the only author to observe 
radiation dose in a large number of patients undergoing PCC with both II and FPDs 
finding an obvious decrease in radiation dose using a FPD.  The introduction of noise 
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reduction algorithms using newer FPD compared to older FPD however resulted in a 
56% dose reduction in patients observed by Haas et al[39].      
 
Limitations and recommendations 
Despite a consensus by two additional reviewers who assessed the scoring performed 
for article quality, this review may have benefitted from these reviewers scoring the 
articles independently and then comparing quality scores.  This may have avoided 
potential bias and helped to identify any areas of debate.  Although DAP readings 
were subject to quality assurance, published E estimates used either monte carlo 
software or conversion factors to provide E however both of these methods provide 
on crude estimates due to their inaccuracies of up to 40%[23,32]. 
 
The conversion of AK from cGy to mGy and DAP from μGycm² to cGycm² for 
comparing the data between studies was trivial however heterogeneous data meant 
that only a summary of the qualitative data has been discussed and therefore limited 
conclusions that can be taken.  Comparing larger cohort studies  also remains 
informal due to the considerable variation in practice between imaging centres.  
Variations in clinical practice were insufficiently documented and include 
fluoroscopy pulse rate, number of CINE acquisitions, use of the anti-scatter grid, use 
of additional X-ray filtration and use of magnification.  It is known that these factors 
vary in current UK practice that they have a substantial effect upon radiation dose[4].  
Although two studies found that average CINE acquisitions were greater for balloon 
dilatation studies, there was paucity of this data found. Overall the types of CINE data 
published such as CINE DAP or CINE times varied considerably and were scarce. 
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Numerous studies presented mean DAP only, rather than median [8,14,16,19-21,23-
27,29,31,38,49].   Contrary to this, data presented from the interquartile range such as the 
median and in particular the 75th percentile is instead recommended by recent 
European diagnostic reference levels for paediatric imaging (PiDRL) guidelines[50].  
In harmony with this, larger and more recent studies in the review (n=>1000)[9-12,18] 
have published their radiation doses as median values.  This method should be used 
for future dosimetry in PCC.  There was a wide variation in radiation dose units 
published and as well categorisations of patient size and procedural type.  This meant 
that there were inconsistent weight categorisation and procedure types for 
comparison.  As well as recommending DAP as the basic quantification of radiation 
dose followed by AK and fluoroscopy time, the recent European PiDRL guidelines[50] 
have also identified the following appropriate weight categories for paediatric 
fluoroscopy: (1) < 5 kgs, (2) 5 – < 15 kg, (3) 15 - < 30 kg, (4) 30 - < 50 kg and (5) < 
80 kg.  In addition to these recommendations future attention should be given to 
developing methods of improving the ease of reporting radiation doses from PCC by 
making the best use of electronic information systems.  At present the UK National 
Patient Dose Database collates information from typical radiation doses to patients 
however radiation dose from PCC has yet to be collated and published[51]. 
 
Conclusion 
Larger studies in this review suggest that radiation dose in PCC has been lowered in 
recent years but it remains varied and substantial.  Caution should be given to 
categorising anticipated radiation dose according to “diagnostic” and “interventional” 
procedures because diagnostic radiation doses can be greater on occasions.  Emphasis 
should be placed on the purpose of the procedure and weight.  Median DAP followed 
 15 
by AK and FT is recommended as the most basic radiation dose estimates for these 
groups.  The number of CINE acquisitions may be useful for comparing data.  The 
large variation in radiation dose suggests that further attention should be given to 
optimising the radiation dose and standardisation of practice between imaging centres. 
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Figure 1 Summary of literature review search using the Transparent Reporting 
of Systematic Reviews and Meta-Analysis group flow chart (2009). 
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Table 1 Summary of keywords searched in the systematic literature review. 
 
 
 
1st term 2nd term 3rd term 
 
Pediatric 
OR 
Cardiac 
OR 
Radiation dose 
OR 
Paediatric 
OR 
Catheterization 
OR 
Radiation exposure 
OR 
Newborns 
OR 
Catheterisation 
OR 
Radiation protection 
OR 
Adolescents 
OR 
Cardiology 
OR 
Radiation injuries 
OR 
Infants 
OR 
Interventional cardiology Reference levels 
OR 
Children 
OR 
 Dose reduction 
OR 
Congenital heart disease 
OR 
 Dose optimization 
OR 
  Dose optimisation 
OR 
  Ionising radiation 
OR 
  Ionizing radiation 
OR 
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Table 2 Characteristics of the 31 articles in the systematic literature review. 
 
 
Lead author Year Patients (n)  Country X-ray detector Quantities Quality 
score 
Al-Haj [21] 2008 190 Saudi Arabia II DAP, FT, DA, E,  5 
Ait-Ali [8] 2010 18 Italy unknown DAP, FT, E  6 
Bacher [20] 2005 60 Belgium II DAP, FT, DA, E, 
PSD   
7 
Barnaoui [17] 2014 801 France FPD DAP, FT, E, O, 
DA  
 
6 
Beels [38] 2009 49 Belgium II DAP, FT, DA, E  6 
Boothroyd [26] 1997 50 UK II DAP, ESD 6 
Chida [31] 2010 239 Japan II DAP, FT, DA  7 
Dragusin [50] 2008 273 Belgium FPD DAP, FT, DA  6 
El Sayed [24] 2012 107 Egypt II DAP, FT, DA, E, 
AK  
6 
Ghelani [12] 2014 2,713 USA unknown DAP, FT 
 
6 
Gherardi [56] 2011 200 UK FPD DAP, E, 
 
7 
Glatz [18] 2014 2,265 USA FPD DAP, FT, E AK,  
 
7 
Haas [39] 2015 667 Germany FPD DAP, FT 7 
Harbron [10] 2015 7,726 UK FPD/II DAP, FT, E, AK, 
O  
6 
Karambatsakidou [23] 2009 249 Germany II DAP, E, PSD  5 
Kobayashi [9] 2014 8,267 USA FPD/ II DAP, FT 
 
7 
Li [7] 2001 18 Japan II ESD, FT, DA,  O 5 
Martinez [25] 2007 137 Spain FPD DAP, ESD, PSD 5 
McFadden [14] 2013a 354 UK II DAP, FT 7 
Mesbahi [30] 2008 32 Iran FPD DAP, FT, DA, 
AK,  
5 
Moore [13] 1999 25 USA II FT, DA, ESD, O 5 
Papadopoulou  [15] 2005a 46 Greece II FT, DA, ESD, O 6 
Papadopoulou  [29] 2005b 45 Greece II ESD, O 6 
Schueler [55] 1994 175 USA II DAP, FT, DA  5 
Shim [28] 2000 24 USA II ESD, DA, FT, O 5 
Song [19] 2015 90 China FPD DAP, FT, E PSD  7 
Tsapaki [27] 2008 40 Greece II DAP, FT 6 
Verghese [11] 2012 3,365 USA FPD DAP, FT, AK  
 
7 
Walsh [52] 2015 99 Canada FPD DAP, FT, DA 6 
Yakoumakis [22] 2009 98 Greece II ESD, E 5 
Yakoumakis [16] 2013 53 Greece II DAP, ESD, O 6 
 
 
DAP - Dose area product, PSD - Peak Skin dose, E - Effective dose, DA – Digital acquisition data, FT- 
Fluoroscopy time, O - Organ dose, AK – air kerma, ESD – Entrance surface dose 
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Table 3 Mean dose area product observations. 
 
 
 
Lead author Year Mean Diagnostic DAP 
(cGycm²) (min-max) 
Mean Interventional 
DAP (cGycm²) (min-
max) 
All 
procedures 
DAP 
(cGycm²)  
     
Al-Haj 2008 777 1,085 
 
 
Ait-Ali 2010 2,080 (100 - 6500) 10,900 (1,200 - 27,700) 
 
 
Bacher 2005 442.5 (96 - 1461) 1,085 
 
 
Barnaoui  2014 490 536 
 
 
Beels 2009 555 270 
 
 
Boothroyd 1997 1,332.5  (558 - 15,860) 3,402.1 (126 - 20,239) 
 
 
Chida 2010 1,702 2,242 
 
 
El Sayed 2012 377.5 1,323.9 
 
 
Haas 2015 
 
  2343 
Karambatsakidou 2009 2,088 1,156 
 
 
Martinez 2007 470 (190 - 860) 830 (240 - 1,780) 
 
 
Mesbahi 2008 
 
  200 
McFadden 2013a 294 (10 - 5,648) 312.9 (13 - 7,961) 
 
 
Papadopoulou  2005a 411 (46 - 1,360) 873 (218 - 3,266) 
 
 
Papadopoulou  2005b 355 (36 - 1,360) 
(Posterior detector 
only) 
572 (63 - 3,320) 
(posterior detector 
only) 
 
     
Tsapaki 2008 
 
(10 - 3,670) (150 - 19,480)  
Song 
 
2015 - 1,339  
Yakoumakis 2013  2,230 
 
 
Walsh 2015 - 243  
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Table 4 Median dose area product observations. 
 
 
 
Lead author 
 
Year Diagnostic Median 
DAP (cGycm²) (range)   
Interventional 
Median DAP 
(cGycm²) (range) 
 
All 
procedure
s 
Median 
DAP 
(cGycm²) 
(range) 
     
Dragusin 2008 (250 - 990) (480 - 4,680)  
 
Glatz 
 
2014 
 
(612 - 8,959) 
 
(258 - 15,841) 
 
 
Ghelani 2014 
 
 (70 - 2,300)  
Gherardi 2011   200 
 
Harbron 2015 (186 - 71,240) (225 - 26,930)  
 
Haas 2015 
 
  396.3 
Kobayashi 
 
2014 (288 - 10,347) (279 - 11,600)  
Schueler 1994   2,112* 
(376 - 
12,467) 
Papadopoulou  2005
a 
360 873 - ASD 
2,223 - VSD 
 
 
Verghese 2012 215 - 1,247 797 - 30,067  
 
 
*Radiation dose measured as R-CM² 
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Table 5 Summary of effective dose observations. 
 
 
Lead author Year Mean effective dose 
(mSv) (min-max) 
 
Median effective dose (mSv) 
(min-max) 
 
Al-Haj 
 
2008 
 
D 8.7 
I 13.5 (4 - 19.9) 
 
 
Bacher 2005 D (0.6 - 23.2) 
I (1 - 37) 
 
 
Barnaoui 2014 D 5.3 (0.3 - 23) 
I 5.68 (0.3 - 48.4) 
 
 
Beels 2009  6.4 
    
Dragusin 2008  I 8.05 
    
El-Sayed 2012 D 3.42 
I 5.97 
 
 
Glatz 2014  D 4.8 -15.2 
   I 5.5 - 25.7 
 
Gherardi 2011  D 5 (0.2 - 27.8) 
 
Harbron 2015  6.7 
 
Karambatsakidou 2009 (0.2 - 77.2) 
 
 
Song 2015 I 7.72 
 
 
Yakoumakis 2009 D 3.71 (0.16 - 16.44) 
I 5 (0.38 - 25.01) 
D 2.9 (0.16 - 16.44) 
I 3.48 (0.38 - 25.01) 
 
Yakoumakis 2013 I 26 (17 - 40)  
 
 
 
 
D – Diagnostic 
I – Interventional 
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Table 6 Summary of peak skin dose observations. 
 
 
 
Study Year Mean (mGy) Median (range) mGy) 
 
 
Bacher 
 
2005 
  
34.2 (12.1 - 144) Posterior 
   23.9 (1.49 - 297) Lateral 
 
Karambatsakidou 2009 16 (0 - 60) Posterior  
    
Martinez 2007 D 51.75   
  I 98  
 
 
Song 2015 79 PDA 42 (2 - 250) 
  140  VSD 120 (4 - 320) 
  91 ASD 49 (3 - 410) 
  190  RFA 140 (4 – 1,020) 
  83  PV 74 (4 - 160) 
 
 
 
 
 
 
D - Diagnostic 
I - Interventional 
PV - Pulmonary valvuloplasty 
RFA - Radiofrequency ablation 
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Table 7 Summary of organ radiation dose observations. 
 
Lead author Year Mean absorbed dose 
(mGy) 
Median equivalent 
dose range (mSv) 
Mean equivalent 
dose (mSv) 
Barnaoui 2014 Thyroid 8.4   
  Breasts 15.75   
  Lungs 33.45   
  Oesophagus 26   
Harbron 2015  Thyroid 0.4 - 2.9  
   Breasts 5.7 - 69.2  
   Heart 9.5 - 72.4  
   Lungs 9.4 - 93.7  
   Lymph nodes 2 - 16.2  
   Oesophagus 7 - 54.4  
   Liver 2.3  
   Stomach 18.5  
Li 2001 Thyroid right side 13.6   
  Thyroid left side    8.3   
Moore 1999 D thyroid  5   
  I  Thyroid 9.5   
  D gonads 0.6   
  PDA gonads 2   
  PV gonads 1   
Papadopoulou  2005a D thyroid 2 (0.5 - 4) 
I thyroid 3.45 (0.4 - 8.3) 
  
  D gonads 0.2 (0.1 - 0.3)   
  I gonads 0.4 (0.1 - 2.1)   
Papadopoulou  2005b D thyroid 6.9 
I thyroid 9.2 
  
  D gonads 0.2   
  I gonads 0.2   
Shim 2000 D thyroid 6.9   
  ASD thyroid 9.2   
  D gonads 2   
  ASD gonads2.2   
Yakoumakis 2013   Thyroid 3.4 
    Breasts 87.8 
    Heart 90.4 
    Lungs 42 
    Liver 28 
    Stomach 34.7 
    Thymus 122.5 
    Pancreas 25.7 
    Skin 6.8 
    Spleen 16.9 
D – Diagnostic, I – Interventional, ASD – Atrial septal defect 
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